Deoxyuridine suppression: Biochemical basis and diagnostic applications
Blood Reviews, ISSN: 0268-960X, Vol: 2, Issue: 3, Page: 168-177
1988
- 24Citations
- 5Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations24
- Citation Indexes24
- 24
- CrossRef20
- Captures5
- Readers5
Article Description
The deoxyuridine (dU) suppression test evolved out of investigations into the biochemical basis of the megaloblastic changes seen in vitamin B 12 and folate deficiency. Although the abnormality in dU suppression which occurs in vitamin B 12 - or folate-deficient states is assumed to reflect impaired methylation of deoxyuridylate, there is still no direct demonstration that this is so. Furthermore, there is evidence that reactions other than the methylation of deoxyuridylate are involved in the phenomenon of dU suppression. Nevertheless, in clinical practice abnormal dU suppression serves as a sensitive index of the presence of megaloblastosis due to vitamin B 12 or folate deficiency. dU suppression is also abnormal in a number of conditions other than vitamin B 12 or folate deficiency, but its overall specificity in detecting tissue dysfunction due to these two deficiency states is considerably higher than that of the serum vitamin B 12 or red cell folate levels. Consequently, the test enables us simply and rapidly to define those patients in whom macrocytosis is unrelated to a deficiency of vitamin B 12 or folate. For these reasons, the dU suppression test has been adopted by several laboratories across the world for investigating patients with (a) possible vitamin B 12 or folate deficiency, (b) macrocytosis, and (c) megaloblastic erythropoiesis. Since the dU suppression test is abnormal in transcobalamin II deficiency and in some congenital disorders of vitamin B 12 and folate metabolism, it is very useful in the investigation of obscure anaemias in infancy and childhood. In addition, it has contributed to our understanding of the mechanisms underlying the myelotoxicity of certain drugs, and particularly of nitrous oxide.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0268960X88900227; http://dx.doi.org/10.1016/0268-960x(88)90022-7; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0023759683&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/3052662; http://linkinghub.elsevier.com/retrieve/pii/0268960X88900227; http://api.elsevier.com/content/article/PII:0268960X88900227?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:0268960X88900227?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/0268960X88900227; http://dx.doi.org/10.1016/0268-960x%2888%2990022-7; https://dx.doi.org/10.1016/0268-960x%2888%2990022-7
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know